Health - HealthQuill

Novo Nordisk A/S’s data from a clinical trial of a weight-loss medicine, treating overweight and obese adult participants, showed patients lost about 23% of their body weight compared to a dummy group’s 2-3%.

Health

GLP-1 drugs may stop early-stage cancers from spreading, new data shows

HQ Team July 28, 2026: People taking GLP-1 drugs (glucagon-like peptide-1 receptor agonists, the same class as Ozempic and Wegovy) for diabetes alongside.

by HealthQuill
July 28, 2026
0 Comments

Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health services.

Drugs Health

US measles cases hit a 35-year high at 2,295

HQ Team July 22, 2026: The United States has recorded 2,295 measles cases, the highest total in 35 years. The raw number is.

by HealthQuill
July 22, 2026
0 Comments

The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.

Health Research

Pandemic-born four-year-olds read well but struggle to focus: Study

July18,2026: One in three four-year-olds born during England’s first COVID-19 lockdown is struggling to focus, follow instructions, or manage frustration in the classroom.

by HealthQuill
July 20, 2026
0 Comments

US regulator, the FDA has approved Gilead Sciences, Inc.'s supplemental new drug application for treating chronic hepatitis B virus in paediatric patients six years of age and older.

Drugs Health

Scientists map 641 new schizophrenia genes using “Social Network” for DNA

HQ Team June 24,2026: Scientists have discovered 641 previously unknown genes linked to schizophrenia, using a revolutionary method that maps how genes “talk” to.

by HealthQuill
June 24, 2026
0 Comments

Obesity is a health risk that needs to be tackled worldwide

Drugs Health

Retatrutide trial shows 30% body weight loss, rivalling bariatric surgery results

HQ Team June 17, 2026: Retatrutide, an experimental “triple-agonist” weight-loss drug developed by Eli Lilly, helped patients lose nearly a third of their.

by HealthQuill
June 17, 2026
0 Comments

The World Health Organization has posted a repository of more than 450 psychoactive drugs listing their abuses, harms, and dependence.

Drugs Health

Experimental Fentanyl vaccine prevents drug and variants from reaching brain

HQ Team June 15, 2026: Researchers at Scripps Research in California have developed an experimental vaccine that reduced fentanyl levels in the brains.